Showing 411-420 of 450 results for "".
- Horus Pharma Launches Neovis Total Multi for Dry Eye in New Sizehttps://modernod.com/news/horus-pharma-launches-neovis-total-multi-for-dry-eye-in-new-size/2476843/Horus Pharma announced the launch of a new 15ml bottle of Neovis Total Multi for the French, Belgian, and Spanish markets. The product is prescribed as third-line therapy for the treatment of dry eyes with keratitis or dry keratoconjunctivitis, following unsuccessful treatment with low-viscosity
- Market Scope: Advancing Technology Drives Ophthalmic OR Microscope Market to 6 Percent Growth by 2024https://modernod.com/news/market-scope-advancing-technology-drives-ophthalmic-or-microscope/2476746/Manufacturers continue to push the envelope integrating advanced technology into the surgical suite with their top-of-the-line ophthalmic OR microscopes, bringing 4K and 3-D heads-up display with integrated diagnostics—for those who can afford the price tag. Market Scope expects the global
- Clerio Vision Acquires Manufacturer of Extreme H2O Contact Lenseshttps://modernod.com/news/clerio-vision-acquires-manufacturer-of-extreme-h2o-contact-lenses/2476732/Clerio Vision announced that it has acquired Hydrogel Vision Corporation (HVC), a manufacturer and distributor of contact lenses. Terms of the deal were not disclosed. HVC, founded in 2002, is best known for its Extreme H2O product line and its multiple differentiated offerings that
- Alcon Launches New Dailies Colors Contact Lenseshttps://modernod.com/news/alcon-launches-new-dailies-colors-contact-lenses/2476702/Alcon officially announced the launch of new Dailies Colors contact lenses—daily disposable contact lenses that combine eye color enhancement with the convenience of a daily wear, according to a company news release. The new line features four colors—Mystic Blue, Mystic Gray, Mystic Hazel and Mys
- Eyepromise Introduces Screen Shield Pro All-Natural Eye Vitamin for Screen Time Protection for Adultshttps://modernod.com/news/eyepromise-introduces-screen-shield-pro-all-natural-eye-vitamin-for-screen-time-protection-for-adults/2476661/EyePromise announced the introduction of Screen Shield Pro to its premium eye vitamin line. EyePromise’s Screen Shield Pro is designed to protect and relieve the associated symptoms of digital eye strain of adults (ages 18 and up) who spend 8+ hours staring at digital screens while working, gami
- A Single Course of Provention’s PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least 2 Yearshttps://modernod.com/news/a-single-course-of-proventions-prv-031-teplizumab-delays-type-1-diabetes-onset-in-high-risk-individuals-by-at-least-2-years/2476644/Provention Bio announced that results from the National Institutes of Health (NIH)-sponsored “At-Risk” Study were published on-line in The New England Journal of Medicine and presented at the Scientific Sessions of the 79th Annual American Diabetes Association (ADA) meeting.
- Eyepromise Introduces Screen Shield Teen All-Natural Eye Vitamin for Screen Time Protectionhttps://modernod.com/news/eyepromise-introduces-screen-shield-teen-all-natural-eye-vitamin-for-screen-time-protection/2476410/EyePromise announced the introduction of Screen Shield Teen to its premium EyePromise eye vitamin line. Screen Shield Teen is an ocular nutrition supplement specially formulated to preserve and support visual comfort and wellness for children ages 4-17. The vast majority of teens in the Un
- MacuLogix Hosts Inaugural AMD Speaker Alliancehttps://modernod.com/news/maculogix-hosts-inaugural-amd-speaker-alliance/2476336/MacuLogix hosted the industry’s first AMD Speaker Alliance meeting. The peer-to-peer event was attended by 25 optometric key opinion leaders who are at the front lines of minimizing vision loss due to AMD and other retinal disease. “This meeting is helping us kick off a movement in our pro
- Leica Biosystems Receives US Patent for RTF Extreme Speed Scanning Technologyhttps://modernod.com/news/leica-biosystems-receives-us-patent-for-rtf-extreme-speed-scanning-technology/2476211/Leica Biosystems announced that the US Patent Office has granted it a patent for RTF, its “Real-Time Focusing” technology (US patent 9,841,590). Leica says this will enable high volume, extremely fast line scanning of anatomic pathology slides. “RTF technology dramaticall
- Topical Presbyopia Treatment Advances in Clinical Developmenthttps://modernod.com/news/presbyopia-therapies-announces-primary-safety-and-efficacy-resutls-in-phase-2b-study-of-topical-presbyopia-treatment/2479978/Presbyopia Therapies announced that the primary efficacy and safety endpoints have been met in a phase 2b study of its PRX ophthalmic solution. PRX demonstrated a 3 line or greater improvement in monocular distance corrected near acuity in patients between the ages of 48 and 64, with this improve